Back to Journals » Cancer Management and Research » Volume 12

Original Research

FOLFOX vs FOLFIRI as Second-line of Therapy After Progression to Gemcitabine/Nab-paclitaxel in Patients with Metastatic Pancreatic Cancer

       
Total article views   HTML views PDF downloads Totals
11,202 Dovepress* 10,128+ 782 10,910
PubMed Central* 1,074 163 1,237
Totals 11,202 945 12,147
*Since 19 October 2020

View citations on PubMed Central and Google Scholar